{"id":441421,"date":"2021-02-23T02:03:08","date_gmt":"2021-02-23T07:03:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441421"},"modified":"2021-02-23T02:03:08","modified_gmt":"2021-02-23T07:03:08","slug":"renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/","title":{"rendered":"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Feb.  22, 2021  (GLOBE NEWSWIRE) &#8212; Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (\u201c<strong>RenalytixAI<\/strong>\u201d or the \u201c<strong>Company<\/strong>\u201d), the artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its financial results for the six and three months ended December 31, 2020 on Tuesday, March 2, 2021.<\/p>\n<p>\n        <strong>Analyst conference call<\/strong>\n      <\/p>\n<p align=\"justify\">The Company will hold an analyst conference call at 8:30 a.m. (EST) \/ 1:30 p.m. (GMT) p.m. on Tuesday, March 2, 2021. James McCullough, CEO and O. James Sterling, CFO will discuss the financial results and provide a corporate update.<\/p>\n<p>\n        <strong>Conference Call Details<\/strong><br \/>\n        <br \/>US\/CANADA Participant Toll-Free Dial-In Number: (833) 614-1551<br \/>US\/CANADA Participant International Dial-In Number: (914) 987-7290<br \/>United Kingdom Dial-In Number: 08000 288 438<br \/>United Kingdom, London Dial-In Number: 020 3107 0289<br \/>Conference ID: 8982902<\/p>\n<p>\n        <strong>Webcast Registration link:<\/strong>\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zu2Wm1rC-GbGlQNiNmbBvJm5ijaQxd9_XTGsKiOT3y366-hrffSuQgsbO8H6AXFRv4OMisPCixqyI6UTyGc_nIjf69G-9oM2Tc84PcF0fcn2uRY3-ySTdC1PpnXUHSdcuOhyc18KP7Z0EsC8QYZ7gA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/vmhxbo58<\/a><\/p>\n<p>\n        <strong><br \/>\n          <em>For further information, please contact:<\/em><br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>UK Investor Contact:<\/strong>\n          <\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Walbrook PR\u00a0Limited<br \/>Paul McManus \/ Lianne Cawthorne<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>Tel: 020 7933 8780 <\/strong>or\u00a0<a href=\"mailto:renalytix@walbrookpr.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">renalytix@walbrookpr.com<\/a><br \/>Mob: 07980 541 893 \/ 07584 391 303<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>US Investor Contact:<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Gilmartin Group<br \/>Carrie Mendivil \/ Mary Kate McDonough<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <a href=\"mailto:investors@renalytixai.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@renalytixai.com<\/a><br \/>\n            <br \/>415-937-5405<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About Kidney Disease\u00a0<br \/><\/strong>Kidney disease is now recognized as a public health epidemic affecting over 850 million people globally.\u00a0The Centers for Disease Control and Prevention (CDC) estimates that 15% of US adults, or 37 million people, currently have chronic kidney disease (CKD).\u00a0Further, the CDC reports that 9 out of 10 adults with CKD do not know they have it and 1 out of 2 people with very low kidney function who are not on dialysis do not know they have CKD*. Kidney disease is referred to as a &#8220;silent killer&#8221; because it often has no symptoms and can go undetected until a very advanced stage.\u00a0Each year kidney disease kills more people than breast and prostate cancer.\u00a0Every day, 13 patients in the United States die while waiting for a kidney transplant.<br \/>*<em>\u00a0<\/em><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zu2Wm1rC-GbGlQNiNmbBvLwzMY40UvaCL6ZMYM4az2G72rxtAAfbTLEAiyHpSaT11FkMHODjEQvzU21KPIv5-T3HlQDkPiKbB-A5b0LGq3OQScLi6mgYFUmkavrAOZJEmAtDDaAdtRQH1yFCZeLWXaWQOWEm-BJm8VvSCebZes7Qnhg3be0j8ev5a2D7SN4pu9h4afnMEqTLMYgyF_wic5fXX085OW2x2RgaG729h3Q_u2rZvjiBWwiJQPAl2ixq\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.cdc.gov\/kidneydisease\/publications-resources\/2019-national-facts.html<\/a><\/p>\n<p align=\"justify\">\n        <strong>About RenalytixAI<br \/><\/strong>RenalytixAI is a developer of artificial intelligence-enabled clinical <em>in vitro<\/em> diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI&#8217;s products are being designed to make significant improvements in kidney disease diagnosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6AkKxbSNE6PqIMo8fL2iJd-E7LjD83INIc_rc9DlbsVgEWreEF-NJCGBlE6KiVH9C1kg3xTvqK1iTbuDTJXzqsIn1Ztniu1O5gTJYtmT4F0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.renalytixai.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>Forward Looking Statements<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>This press release contains forward-looking statements that are based on management\u2019s beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize and achieve market acceptance of our current and planned products and services, our research and development efforts, and other matters regarding our business strategies, use of capital, results of operations and financial position, and plans and objectives for future operations. <\/em>\n      <\/p>\n<p align=\"justify\">\n        <em>In some cases, you can identify forward-looking statements by the words \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpotential,\u201d \u201ccontinue,\u201d \u201congoing\u201d or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors are described under &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in the documents we file with the Securities and Exchange Commission from time to time. We caution you that forward-looking statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent our views as of the date hereof. We undertake no obligation to update any forward-looking statements for any reason, except as required by law.<\/em>\n      <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/46c0cf86-d552-430c-9449-77276b53da88\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytixAI\u201d or the \u201cCompany\u201d), the artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its financial results for the six and three months ended December 31, 2020 on Tuesday, March 2, 2021. Analyst conference call The Company will hold an analyst conference call at 8:30 a.m. (EST) \/ 1:30 p.m. (GMT) p.m. on Tuesday, March 2, 2021. James McCullough, CEO and O. James Sterling, CFO will discuss the financial results and provide a corporate update. Conference Call Details US\/CANADA Participant Toll-Free Dial-In Number: (833) 614-1551US\/CANADA Participant &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;RenalytixAI to announce Financial Results for six and three months ended December 31, 2020&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441421","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytixAI\u201d or the \u201cCompany\u201d), the artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its financial results for the six and three months ended December 31, 2020 on Tuesday, March 2, 2021. Analyst conference call The Company will hold an analyst conference call at 8:30 a.m. (EST) \/ 1:30 p.m. (GMT) p.m. on Tuesday, March 2, 2021. James McCullough, CEO and O. James Sterling, CFO will discuss the financial results and provide a corporate update. Conference Call Details US\/CANADA Participant Toll-Free Dial-In Number: (833) 614-1551US\/CANADA Participant &hellip; Continue reading &quot;RenalytixAI to announce Financial Results for six and three months ended December 31, 2020&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T07:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020\",\"datePublished\":\"2021-02-23T07:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/\"},\"wordCount\":661,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/\",\"name\":\"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=\",\"datePublished\":\"2021-02-23T07:03:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/","og_locale":"en_US","og_type":"article","og_title":"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 - Market Newsdesk","og_description":"NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytixAI\u201d or the \u201cCompany\u201d), the artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its financial results for the six and three months ended December 31, 2020 on Tuesday, March 2, 2021. Analyst conference call The Company will hold an analyst conference call at 8:30 a.m. (EST) \/ 1:30 p.m. (GMT) p.m. on Tuesday, March 2, 2021. James McCullough, CEO and O. James Sterling, CFO will discuss the financial results and provide a corporate update. Conference Call Details US\/CANADA Participant Toll-Free Dial-In Number: (833) 614-1551US\/CANADA Participant &hellip; Continue reading \"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T07:03:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020","datePublished":"2021-02-23T07:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/"},"wordCount":661,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/","name":"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=","datePublished":"2021-02-23T07:03:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYyMCMzOTg5Njk3IzIyMDEwMjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytixai-to-announce-financial-results-for-six-and-three-months-ended-december-31-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"RenalytixAI to announce Financial Results for six and three months ended December 31, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441421"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441421\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}